{
    "Trade/Device Name(s)": [
        "GBI TSH Neonatal Screening Kit"
    ],
    "Submitter Information": "Golden Bridge International, Inc.",
    "510(k) Number": "K072458",
    "Predicate Device Reference 510(k) Number(s)": [
        "K972458"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JLW"
    ],
    "Summary Letter Date": "March 10, 2008",
    "Summary Letter Received Date": "March 12, 2008",
    "Submission Date": "03/27/08",
    "Regulation Number(s)": [
        "21 CFR 862.1690"
    ],
    "Regulation Name(s)": [
        "Thyroid Stimulating Hormone Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroid Stimulating Hormone (TSH)"
    ],
    "Specimen Type(s)": [
        "Neonatal whole blood collected onto filter paper and dried"
    ],
    "Specimen Container(s)": [
        "Whatman 903 specimen collection paper"
    ],
    "Instrument(s)/Platform(s)": [
        "Microplate spectrophotometer (at 450 nm)"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Sandwich enzyme immunoassay",
        "Spectrophotometric absorbance at 450 nm"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for GBI TSH Neonatal Screening Kit for quantitative determination of TSH in neonatal dried blood spots using EIA methodology",
    "Indications for Use Summary": "Quantitative determination of TSH concentrations in neonatal blood samples collected on filter paper to screen newborns for congenital hypothyroidism",
    "fda_folder": "Clinical Chemistry"
}